<DOC>
	<DOCNO>NCT00001859</DOCNO>
	<brief_summary>Kidney transplantation prefer treatment end-stage kidney disease . This procedure limit , however , two major factor : 1 ) shortage donor organ 2 ) organ rejection recipient . The National Institute Diabetes Digestive Kidney Diseases screen patient kidney failure diabetes may eligible kidney , kidney pancreas , islet cell transplantation . Patients screen study offer treatment . When screen complete , patient offer opportunity participate another institute study , , active study appropriate patient , option suggest primary refer physician . Patients find eligible study obligate participate . Screening patient typically consist blood test , urinalysis , electrocardiogram , PPD tuberculosis screen pregnancy test . Chest kidney X-rays study may do patient determine eligible particular study , include transplantation . A summary test result send refer physician unless patient request otherwise .</brief_summary>
	<brief_title>Screening Patients Needing Kidney , Kidney-Pancreas , Islet-Cell Transplant</brief_title>
	<detailed_description>This protocol design screen patient renal failure and/or diabetes may eligible kidney , kidney-pancreas , islet cell transplantation . Its purpose allow detail investigation renal endocrine function patient , status organ system would determine ability safely tolerate specific aspect therapeutic research protocol . After completion screen process , patient either offer chance participate active treatment protocol , appropriate protocol identify , recommendation treatment option relay primary refer physician .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients enter protocol time first visit NIH Clinical Center Outpatient Clinic Inpatient Services : The patient carry diagnosis disorder Transplant Branch active research interest , base information receive outside physician , meet preliminary eligibility criterion specific research protocol . The patient patient 's guardian capable providing informed consent , sign inform consent initial counsel clinical staff . Separate consent form interventional procedure obtain explanation specific procedure . EXCLUSION CRITERIA : History know malignancy except basal cell carcinoma skin . Inability give legal inform consent self legal guardian . Inability willingness comply protocol monitoring therapy , include , among others , history noncompliance , circumstance compliance protocol requirement feasible due living condition , travel restriction , access urgent medical service , access antirejection drug research protocol complete .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 30, 2014</verification_date>
	<keyword>Evaluation</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Renal Failure</keyword>
</DOC>